General Info

PharmaSeq is a genomics company that has developed the world's first light-powered microtransponders and nanotransponders for performing nucleic acid-based assays. It is a biotechnology company with corporate headquarters and research and development facilities near Princeton, N.J. The company has eight United States patents for microtransponder-based assays and technology and more patents pending. PharmaSeq's strategy is to apply microtransponder technology to DNA probe diagnostics, single nucleotide polymorphism detection and proteomics.